Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
06/2007
06/14/2007US20070134279 Fast-acting oral peptide pharmaceutical products
06/14/2007US20070134273 Composition and method for the treatment of carcinoma
06/14/2007US20070134266 Growth hormone-containing formulation and method of use
06/14/2007US20070134262 Polypeptide encoded by an alternative reading frame of a pathogenic virus or a fragment comprising more than 7 amino acids; Hepatitis A virus, Hepatitis B virus, Hepatitis C virus, Hepatitis D virus, Hepatitis E virus, Hepatitis F virus Hepatitis G virus, Human Immunodeficiency virus, Influenza virus
06/14/2007US20070134261 Effectors of innate immunity
06/14/2007US20070134260 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
06/14/2007US20070134259 Methods and compositions for pharmacologially controlled targeted immunotherapy
06/14/2007US20070134258 Gasp1: a follistatin domain containing protein
06/14/2007US20070134257 Metal-binding therapeutic peptides
06/14/2007US20070134255 Hmpv treatment with ribavirin and anti-hmpv antibody
06/14/2007US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas
06/14/2007US20070134252 Using tumor biomarkers to prognose cancer progression and designing antitumor agent which decrease signal from growth factor receptors
06/14/2007US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3
06/14/2007US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon
06/14/2007US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases
06/14/2007US20070134237 Human cytokine receptor
06/14/2007US20070134232 Topical bite care composition
06/14/2007US20070134231 Method for prolonging activity of autodegradable enzymes and compositions thereof
06/14/2007US20070134230 Method for prolonging activity of autodegradable enzymes
06/14/2007US20070134229 Non-native constitutively active osteopontin
06/14/2007US20070134228 Immunoaffinity purification
06/14/2007US20070134227 Catalyst for cleaving sugar chain
06/14/2007US20070134225 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject
06/14/2007US20070134224 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject
06/14/2007US20070134223 Choroid plexus device
06/14/2007US20070134222 Blood brain barrier device
06/14/2007US20070134221 Stabilizing peptides
06/14/2007US20070134213 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration
06/14/2007US20070134211 Differentiation of adipose stromal cells into osteoblasts and uses thereof
06/14/2007US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents
06/14/2007US20070134200 Immunogenic composition and methods
06/14/2007US20070134199 a surface active substance, in particular a non-ionic detergent (tenside), and a mixture of at least two amino acids, are either Glu and Gln or Asp and Asn for stabilization of protein agents in pharmaceuticals
06/14/2007US20070134198 Composition and use of RAR antagonists for promoting chondrogenesis
06/14/2007US20070134197 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination
06/14/2007US20070134193 Cosmetic and/or pharmaceutical preparations
06/14/2007US20070134155 useful in the treatment of heart failure, cardiac arrhythmias and other diseases where fibrosis is prominent such as in COPD, liver fibrosis, and atherosclerosis comprising a targeting moiety that demonstrates a higher binding affinity to the AT1 receptor than the native octapeptide Ang II
06/14/2007US20070134153 Lipid-based drug delivery systems against parasitic infections
06/14/2007US20070134136 Disinfecting composition
06/14/2007DE102006051512A1 Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin Pharmaceutical compositions medication with cyclosporine
06/14/2007CA2856436A1 Uses of myostatin antagonists
06/14/2007CA2639696A1 Pharmaceutical compositions comprising cyclosporin
06/14/2007CA2633161A1 Methods and compositions for expanding t regulatory cells
06/14/2007CA2633102A1 Method for preparing a factor h concentrate and the use thereof in the form of a drug
06/14/2007CA2632732A1 Method of using il6 antagonists with proteasome inhibitors
06/14/2007CA2632708A1 Novel peptides and the biological use thereof
06/14/2007CA2632684A1 Protein kinase modulation by hops and acacia products
06/14/2007CA2632581A1 Vip fragments and methods of use
06/14/2007CA2632544A1 Use of myostatin antagonist for treating the effects of hypogonadism
06/14/2007CA2632424A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor
06/14/2007CA2631981A1 Methods and compositions for needleless delivery of binding partners
06/14/2007CA2631716A1 Targeting vector-phospholipid conjugates
06/14/2007CA2628756A1 Interleukin-11 compositions and methods of use
06/14/2007CA2628614A1 Process for the preparation of ferri-succinylcasein
06/13/2007EP1795598A1 Novel peptides
06/13/2007EP1795540A1 Multimeric complexes of antigens and an adjuvant
06/13/2007EP1795539A1 Cell penetrating peptides for intracellular delivery of molecules
06/13/2007EP1795538A1 Peptides for inducing apoptosis in tumor cells
06/13/2007EP1795203A2 Fhit proteins and nucleic acids and methods based thereon
06/13/2007EP1795181A1 Cosmetic and pharmaceutical uses of the dipeptide tyrosine-arginine in combination with niacinamide as substance P antagonist
06/13/2007EP1794298A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells
06/13/2007EP1794287A1 Use of il-17- for maturation of oocytes
06/13/2007EP1794286A1 Use of pregnancy specific glycoprotein for maturation of oocytes
06/13/2007EP1794188A1 Dna replication modulating peptides, nucleic acids encoding them, and their use in pharmaceutical compositions
06/13/2007EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor
06/13/2007EP1794186A2 Group a streptococcus crge protein
06/13/2007EP1794182A2 Compounds that modulate trh actions and inhibit the trh-degrading enzyme
06/13/2007EP1794179A1 Ring-closing metathesis process in supercritical fluid
06/13/2007EP1794178A1 Process for preparing macrocyclic hcv protease inhibitors
06/13/2007EP1793865A2 Gene or drug delivery system
06/13/2007EP1793859A2 Methods of healing wounds by administering human il-18
06/13/2007EP1793856A2 Methods and compositions for treating allergic inflammation
06/13/2007EP1793855A2 Prevention and treatment of synucleinopathic and amyloidogenic disease
06/13/2007EP1793854A1 Treating gliosis, glial scarring, inflammation or inhibition of axonal growth in the nervous system by modulating eph receptor
06/13/2007EP1793847A2 Use of microproteins as tryptase inhibitors
06/13/2007EP1793846A1 Compositions and methods comprising vitamin b12 and an impdh inhibitor for treating viral, inflammatory and proliferative diseases
06/13/2007EP1793845A2 Use of il-28 and il-29 to treat cancer
06/13/2007EP1793844A1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin
06/13/2007EP1793843A1 Macrocyclic sh2 domain binding inhibitors
06/13/2007EP1793842A2 Treatment for cancer-related fatigue
06/13/2007EP1793841A1 Peptide inhibitors of c-jun dimerization and uses thereof
06/13/2007EP1793837A2 Fatty acid modified polylysines as antimicrobial agents
06/13/2007EP1793812A2 Antibiotic compound
06/13/2007EP1793802A1 Controlled and directed local delivery of anti-inflammatory compositions
06/13/2007EP1793764A2 Growth factor encapsulation system for enhancing bone formation
06/13/2007EP1583816A4 Protein arrays
06/13/2007EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof
06/13/2007EP1448456B1 Transdermal/transmucosal patch packaging
06/13/2007EP1408988B1 Compositions of orally administered nutritional supplements to repair articular cartilage
06/13/2007EP1379546B1 Peptide for the diagnosis and therapy of alzheimer's disease
06/13/2007EP1363932B1 Amphoteric sterols and the use thereof
06/13/2007EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus
06/13/2007EP1330425B1 C-nitroso compounds and use thereof
06/13/2007EP1302542B1 Novel physiologically active peptide and use thereof
06/13/2007EP1276474B1 Formulations for use in inhaler devices
06/13/2007EP1276469B1 Taste masking coating composition
06/13/2007EP1267925B1 Treatment of fungal infection with polyene or beta glucan synthase inhibitor antifungals combined with anti hsp90 antibodies
06/13/2007EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
06/13/2007EP1235862B1 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralization antibodies
06/13/2007EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof
06/13/2007EP1220679B1 Cell-based gene therapy for the pulmonary system
1 ... 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 ... 3163